IDEAYA Biosciences Inc.
IDYA | NASDAQ
$39.46
+$0.60 (+1.54%)
Sep 22, 2026, 11:54 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 218.71M | 7M | 23.39M | 50.93M | 27.94M | 19.54M |
Cost of Revenue | 4.59M | 3.83M | 4.01M | 2.1M | 1.73M | 1.38M |
Gross Profit | 214.12M | 3.17M | 19.38M | 48.83M | 26.22M | 18.16M |
Operating Income | -159.31M | -326.98M | -134.43M | -62.5M | -50.27M | -35.34M |
Interest Income | 45.62M | 52.5M | 21.47M | 3.85M | 506K | 849K |
Pretax Income | -113.7M | -274.48M | -112.96M | -58.66M | -49.76M | -34.5M |
Net Income | -113.7M | -274.48M | -112.96M | -58.66M | -49.76M | -34.5M |
Selling & General & Admin | 63.32M | 35.47M | 24.3M | 21.8M | 18.33M | 13.8M |
Research & Development | 314.7M | 294.67M | 129.51M | 89.54M | 58.16M | 39.7M |
Other Expenses | -4.59M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 373.43M | 330.14M | 153.81M | 111.33M | 76.48M | 53.5M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 378.02M | 333.98M | 157.81M | 113.43M | 78.21M | 54.88M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 88.49M | 81.68M | 57.52M | 41.44M | 35.25M | 24.72M |
Shares Outstanding (Diluted) | 88.49M | 81.68M | 57.52M | 41.44M | 35.25M | 24.72M |
EPS (Basic) | -1.28 | -3.36 | -1.96 | -1.42 | -1.41 | -1.31 |
EPS (Diluted) | -1.28 | -3.36 | -1.96 | -1.42 | -1.41 | -1.31 |
EBITDA | -109.11M | -270.64M | -108.95M | -56.55M | -48.04M | -33.11M |
EBIT | -113.7M | -274.48M | -112.96M | -58.66M | -49.76M | -34.5M |
Depreciation & Amortization | 4.59M | 3.83M | 4.01M | 2.1M | 1.73M | 1.38M |
Add to Watchlist
Select watchlists to add or remove IDYA